Hi-tech Pharmacal Co, Inc. (HITK) Income Statement

Click line-items for a historical chart and %

NET SALES	59.9M
Cost of goods sold	27.96M
GROSS PROFIT	31.94M
Selling, general and administrative expenses	14.21M
Research and product development costs	4.45M
Royalty income
Contract research (income)	0
Interest expense	69K
Interest (income) and other	-509K
TOTAL	19.63M
Income from continuing operations before income tax expense	12.31M
Income tax expense	3.96M
Income from continuing operations
Income from discontinued operations, net of tax
NET INCOME	8.35M
Continuing operations
Discontinued operations
BASIC INCOME PER SHARE	0.6
Continuing operations
Discontinued operations
DILUTED INCOME PER SHARE	0.59
Weighted average common shares outstanding-basic	13.86M
Effect of potential common shares
Weighted average common shares outstanding-diluted	14.22M

Entities mentioned with HITK

View All Entities